MYCN and neuroblastoma: Together, these results suggest that PHA-680626 is a strong and effective CD inhibitor, preventing the AURKA/N-Myc interaction in cultured cells, triggering N-Myc degradation, and impairing the viability of neuroblastoma cell lines that are N-Myc-addicted for their proliferation.